USA Today
On Monday, GlaxoSmithKline PLC
asked the federal Food and Drug Administration to approve its drug
Avodart as a cancer preventive for men at higher-than-normal risk of the
disease. The drug is already sold for urinary problems, and no heart
failure risks have been seen with that use, doctors say... read more
Find a Doctor/Researcher
Make an Appointment
Refer a Patient
Make a Gift
Penn Cancer Network
